Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
NCT07096102

Efficacy of a Health Empowerment Theory Based Health Information Literacy Promotion Intervention in Individuals With Metabolic Syndrome

Led by Meihua Ji · Updated on 2025-12-01

310

Participants Needed

4

Research Sites

69 weeks

Total Duration

On this page

Sponsors

M

Meihua Ji

Lead Sponsor

T

The Luhe Teaching Hospital of the Capital Medical University

Collaborating Sponsor

AI-Summary

What this Trial Is About

The ENRICH study is aimed to Enpower patieNts with metabolic syndrome (Mets) to increase their Risk perception and to acquire health Information necessary for Capability building and promotion of Health information literacy, as well as health outcomes. The purpose of this clinical trial is to evaluate the efficacy of this health information literacy promotion intervention based on Health Empowerment Theory in individuals with metabolic syndrome. The study aims to answer the following questions: Does the intervention improve health information literacy among study participants? Does the intervention lead to better health outcomes, including weight, waist circumference, BMI control, and metabolic health indicators (blood pressure, blood glucose, glycated hemoglobin, and blood lipids)? Participants will: Undergo the intervention program for 6 weeks (face to face and online) and will be assessed regularly to monitor changes in terms of their level of health information literacy and health outcomes.

CONDITIONS

Official Title

Efficacy of a Health Empowerment Theory Based Health Information Literacy Promotion Intervention in Individuals With Metabolic Syndrome

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 to 75 years old
  • Diagnosed with metabolic syndrome meeting at least 3 of the following: waist circumference ≥ 90 cm (men) / ≥ 85 cm (women), fasting glucose ≥ 6.1 mmol/L or OGTT 2h-glucose ≥ 7.8 mmol/L or diabetes treatment, blood pressure ≥ 130/85 mmHg or hypertension treatment, fasting triglycerides ≥ 1.70 mmol/L, fasting HDL-C < 1.04 mmol/L
  • Aware of the condition and have basic reading and language communication skills
  • Voluntarily agree to participate in the study
Not Eligible

You will not qualify if you...

  • Severe liver or kidney dysfunction, cancer, severe cardiovascular or cerebrovascular diseases, gout, or other conditions seriously endangering life requiring special diet
  • Pregnancy
  • History of mental illness or cognitive impairment
  • Currently participating in other research projects

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

Songzhuang Community Health Service Center

Beijing, Beijing Municipality, China, 101100

Actively Recruiting

2

Yuqiao Subdistrict Community Health Service Center

Beijing, Beijing Municipality, China, 101100

Completed

3

Li Yuan Community Health Service Center in Tongzhou District, Beijing

Beijing, Beijing Municipality, China, 101121

Enrolling by Invitation

4

Lucheng Subdistrict Community Health Service Center

Beijing, Beijing Municipality, China

Actively Recruiting

Loading map...

Research Team

M

Meihua Ji

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here